These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37849545)

  • 1. Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1318-1319. PubMed ID: 37849545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.
    Sabnis RW
    ACS Med Chem Lett; 2023 Nov; 14(11):1501-1502. PubMed ID: 37974937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):163-164. PubMed ID: 38352824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Isoxazolidines as RIPK1 Inhibitors for Treating Alzheimer's Disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis.
    Sabnis RW
    ACS Med Chem Lett; 2024 Apr; 15(4):447-448. PubMed ID: 38628797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Optimization of Selective Brain-Penetrant EBP Inhibitors that Enhance Oligodendrocyte Formation.
    Dorel R; Sun D; Carruthers N; Castanedo GM; Ung PM; Factor DC; Li T; Baumann H; Janota D; Pang J; Salphati L; Meklemburg R; Korman AJ; Harper HE; Stubblefield S; Payandeh J; McHugh D; Lang BT; Tesar PJ; Dere E; Masureel M; Adams DJ; Volgraf M; Braun MG
    J Med Chem; 2024 Mar; 67(6):4819-4832. PubMed ID: 38470227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
    Sabnis RW; Sabnis AR
    ACS Med Chem Lett; 2024 Jun; 15(6):750-751. PubMed ID: 38894913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jul; 15(7):994-995. PubMed ID: 39015277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Heterocyclic PAD4 Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):179-180. PubMed ID: 38352837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity.
    Moebius FF; Fitzky BU; Wietzorrek G; Haidekker A; Eder A; Glossmann H
    Biochem J; 2003 Aug; 374(Pt 1):229-37. PubMed ID: 12760743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylic Acid-Containing Indanyl Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
    Sabnis RW; Sabnis AR
    ACS Med Chem Lett; 2023 Aug; 14(8):1033-1034. PubMed ID: 37583826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Heterocyclic PAD4 Inhibitors for Treating Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Mar; 15(3):340-341. PubMed ID: 38505857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Aug; 15(8):1180-1181. PubMed ID: 39140039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 May; 15(5):569-570. PubMed ID: 38746891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.